Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2003
11/04/2003US6641063 Milling process for the production of finely milled medicinal substances
11/04/2003CA2266006C Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
10/2003
10/31/2003CA2444598A1 Compositions useful as inhibitors of gsk-3
10/30/2003WO2003089934A2 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1/lap-1
10/30/2003WO2003089903A2 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1)
10/30/2003WO2003089448A1 Ibuprofen ribavirin ester, its method of preparation and use
10/30/2003WO2003089441A1 Tricyclic mercaptans, method for their production and the use thereof as mmp inhibitors
10/30/2003WO2003089440A1 Polymorph of ascomycin derivative
10/30/2003WO2003089439A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof
10/30/2003WO2003089434A2 IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES METHOD OF MAKING AND METHOD OF USE THEREOF
10/30/2003WO2003089430A1 Thioxanthine derivatives as myeloperoxidase inhibitors
10/30/2003WO2003089429A1 Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1,2,4-triazol-3-one
10/30/2003WO2003089428A1 Tricyclic thrombin receptor antagonists
10/30/2003WO2003089427A1 Indol-2-ones as selective inhibitors of cyclooxygenase-2
10/30/2003WO2003089411A1 Derivatives of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics
10/30/2003WO2003089410A1 Phenylalanine derivative
10/30/2003WO2003089405A1 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition
10/30/2003WO2003089010A1 Glycodendrimers having biological activity
10/30/2003WO2003088981A1 Methods of treating necrotizing enterocolitis
10/30/2003WO2003088977A1 (20S)-1α-HYDROXY-2α-METHYL AND 2β-METHYL-19-NOR-VITAMIN D3 AND THEIR USES
10/30/2003WO2003088972A1 Novel compounds
10/30/2003WO2003088956A1 Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide
10/30/2003WO2003088955A1 Pharmaceutical composition comprising an alpha-ketoalkanoic acid ester or -amine and lactic acid or a lactic acid salt
10/30/2003WO2003088945A1 Aerosol containing a particulate active substance
10/30/2003WO2003088944A1 Dry powder inhalant composition
10/30/2003WO2003088908A2 Heterocyclo inhibitors of potassium channel function
10/30/2003WO2003088903A2 Compounds, compositions, and methods
10/30/2003WO2003088900A2 Solid forms of salts with tyrosine kinase activity
10/30/2003WO2003088748A1 Use of heme oxygenase-1 and products of heme degradation
10/30/2003WO2003063796A3 Heterocyclic arylsulfonamidobenzylic compounds
10/30/2003WO2003057919A3 The use of histamine h4 receptor antagonist for the treatment of inflammatory response
10/30/2003WO2003051833A3 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
10/30/2003WO2003051388A3 Pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
10/30/2003WO2003051277A3 Novel compounds
10/30/2003WO2003031568A3 Intracellular signaling molecules
10/30/2003WO2003029264A3 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
10/30/2003WO2003025199A3 Mid 4460, a human tyrosine phosphatase family member and uses therefor
10/30/2003WO2003024455A3 Stent coated with a sustained-release drug delivery and method for use thereof
10/30/2003WO2003024436A3 Method for treating skin disorders
10/30/2003WO2003024419B1 Apoptosis-mimicking natural vesicles and use thereof in medical treatment
10/30/2003WO2003020320A3 Nanoparticles comprising biologically active tnf which is immobilised on the same
10/30/2003WO2003020309A3 Compound
10/30/2003WO2003020287A3 Methods for the treatment of chronic pain anc compositions therefor
10/30/2003WO2003018836A3 Model of autoimmune disease and methods for identifying agents against autoimmune disease
10/30/2003WO2003018619A3 Antimicrobial and anti-inflammatory peptides
10/30/2003WO2003016549A3 Nucleic-acid associated proteins
10/30/2003WO2002098391A3 Process for preparing granular compositions
10/30/2003WO2002098370A3 Methods of administering/dosing cd2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders
10/30/2003WO2002097030A3 Peptides derived from neural thread proteins and their medical use
10/30/2003WO2002094876A3 Methods and compositions for treating respiratory mucin production associated disease conditions
10/30/2003WO2002087563A3 Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
10/30/2003WO2002080978A3 Pharmaceutical compositions comprising ascomycin
10/30/2003WO2002072571A3 Pyridinyl pyrazoles useful for the treatment of copd
10/30/2003WO2002069961A8 Il-8 receptor ligands-drugs for inflammatory and autoimmune diseases
10/30/2003WO2002069901A3 Cathepsin cysteine protease inhibitors
10/30/2003WO2002068617A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/30/2003WO2002066476A9 6-phenylbenzonaphthyridines
10/30/2003WO2002059327A3 Sulfatases and methods of use thereof
10/30/2003WO2002059283A3 Nucleic acid modification enzymes
10/30/2003WO2002042303A3 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
10/30/2003WO2002034783A3 Transmembrane proteins
10/30/2003WO2002020090A9 Pharmaceutical compositions
10/30/2003WO2002018583A9 Modified polypeptides stabilized in a desired conformation and methods for producing same
10/30/2003WO2002002638A3 Methods for treating rheumatic diseases using a soluble ctla4 molecule
10/30/2003US20030204089 Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
10/30/2003US20030204086 Novel heterocyclic amide derivatives
10/30/2003US20030204071 109 human secreted proteins
10/30/2003US20030204049 Which have affinity/targeting vector for integrin receptors; diagnostic imaging
10/30/2003US20030203957 Selected fused pyrrolocarbazoles
10/30/2003US20030203955 Administering to a patient suffering from an immune cell mediated diseases a therapeutic amount of biheterocyclic compound containing sulfone group or substituted suflone
10/30/2003US20030203952 Novel processes for making- and a new crystalline form of- leflunomide
10/30/2003US20030203951 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase
10/30/2003US20030203945 Coupling a heterocyclic compound containing amine group with a 4-nitrophenyl-1-oxycarbonyl or derivative useful for the treatment of neurological conditions
10/30/2003US20030203927 Thrombin receptor antagonists
10/30/2003US20030203926 For treatment of inflammatory or autoimmune condition, viral infection, cancer
10/30/2003US20030203922 Substituted amine derivatives and methods of use
10/30/2003US20030203919 Dipeptide nitrile cathepsin K inhibitors
10/30/2003US20030203915 Compounds that are nitrosated and/or nitrosylated through one or more sites such as oxygen (hydroxyl condensation), sulfur (sulfhydryl condensation) and/or nitrogen
10/30/2003US20030203909 A N-phenyl-benzo(b)thiophene-carboxamide derivatives, as enzyme inhibitor of tyrosine kinase; antiproliferation of lymphocyte, treating autoimmune disease, rheumatic disease, as immunosuppressant, antiinflammatory agents
10/30/2003US20030203905 Inhibitors of p38
10/30/2003US20030203897 2,4-Disubstituted thiazolyl derivatives
10/30/2003US20030203896 Novel guanidino derivatives as inhibitors of cell adhesion
10/30/2003US20030203893 Benzimidazole derivatives, preparation and therapeutic use thereof
10/30/2003US20030203882 For treating psoriasis, inflammation, leukemia, colon cancer, breast cancer or prostate cancer
10/30/2003US20030203865 Lipid-comprising drug delivery complexes and methods for their production
10/30/2003US20030203855 17-Aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
10/30/2003US20030203847 Methods and compositions in treating pain and painful disorders using 9949, 14230, 760, 62553, 12216, 17719, 41897, 47174, 33408, 10002, 16209, 314, 636, 27410, 33260, 619, 15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 16314, 1613, 1675, 9569 or 13424 molecules
10/30/2003US20030203841 T20/DP178 and T21/DP107 are activators of human phagocyte formyl peptide receptors
10/30/2003US20030203396 Human galactosyltransferases
10/30/2003US20030203361 13 human colon and colon cancer associated proteins
10/30/2003US20030203057 A mixture of isoflavones or isoflavone glycosides, pungent, bitter and sour substances and/or scymnol and scymnol esters; secretion of biogenic monoamines; antidepressants; seasonal affective disorder; Alzheimer's disease and much more!
10/30/2003US20030203037 Dosage forms which can be administered parenterally and comprise a suspension of the salt of tramadol and diclofenac
10/30/2003US20030203030 Polymeric gel delivery system for pharmaceuticals
10/30/2003US20030203026 Compressed tablet containing non-steroid antiinflammatory drug
10/30/2003EP1496982A2 Solid forms of salts with tyrosine kinase activity
10/30/2003CA2770411A1 Aerosol containing a particulate active substance
10/30/2003CA2752132A1 Thioxanthine derivatives as myeloperoxidase inhibitors
10/30/2003CA2484017A1 Indol-2-ones as selective inhibitors of cyclooxygenase-2
10/30/2003CA2483409A1 (20s)-1.alpha.-hydroxy-2.alpha.-methyl and 2.beta.-methyl-19-nor-vitamin d3 and their uses
10/30/2003CA2482991A1 Imidazo[1,2-a]pyrazin-8-ylamines method of making and method of use thereof
1 ... 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 ... 1272